Abstract:Supplementary Figures and Tables. /// Supplementary Figure 1. TP53 mutation status in human prostate cancer. /// Supplementary Figure 2. Genotypic and histological characterization of Pten/Trp53/ERG-altered mouse prostates. /// Supplementary Figure 3. Immunohistochemistry and immunofluorescent co-staining of key markers in serially-sectioned mouse prostate tissues. /// Supplementary Figure 4. Transcriptomic characterization of the Pten/Trp53/ERG-mutated mouse prostates. /// Supplementary Figure 5. Western blot analysis of expression of ERG downstream genes and E2F1 targets in human prostate cancer cells. /// Supplementary Figure 6. Analysis of expression of ERG-regulated genes and ERG chromatin binding at these gene loci in human prostate cancer PC-3 cells. /// Supplementary Figure 7. Palbociclib and enzalutamide treatment optimization in human prostate cancer cell lines. /// Supplementary Figure 8. Characterization of LNCaP-RF xenografts and mouse tumor-derived allografts. /// Supplementary Table 1. shRNA sequences. /// Supplementary Table 2. RT-qPCR primer sequences. /// Supplementary Table 3. ChIP-qPCR primer sequences. /// Supplementary Table 4. PCR genotyping primer sequences. /// Supplementary Table 5. Raw staining index scores for AR and ERG IHC of mCRPC human tissue microarray. /// References

Supplementary Figure 1 from <i>pten</i> Expression As a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer

Supplementary Figure 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER+ Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Figure Legend from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplemental Figure 3 from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Figure S2 from Augmentation of Nab-Paclitaxel Chemotherapy Response by Mechanistically Diverse Antiangiogenic Agents in Preclinical Gastric Cancer Models

Supplementary Fig.S12 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Supplementary Figure 5 from Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

Supplementary Figure 2 from an Integrated Genomic Screen Identifies LDHB As an Essential Gene for Triple-Negative Breast Cancer

Supplementary Figure 2 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis

Supplementary Data from Genetically Defined Syngeneic Mouse Models of Ovarian Cancer As Tools for the Discovery of Combination Immunotherapy

Supplementary Figure S6 & Supplementary S6 Legend from Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated with Excessive DNA Damage and Replication Stress

Supplemental Tables from Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer

Supplementary Figures 1-3 from Genetic Background Controls Tumor Development in <i>Pten</i>-Deficient Mice

Supplementary Information from &Lt;i>tmprss2-Erg</i> Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in <i>pten</i> and &Lt;i>tp53</i>-Mutated Prostate Cancer

Supplementary Figure 1 from the ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of P53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma Metastasis

Supplementary Figure S2 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figure 4 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure S3 from Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A

Supplemental Figure S3 from Obesity Contributes to Ovarian Cancer Metastatic Success Through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages

Supplementary Figure 1 from &lt;i&gt;pten&lt;/i&gt; Expression As a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer